ScienceDaily (Sep. 27, 2008) — Activation of the Src signaling pathway may cause resistance to standard medical treatment in some patients with breast cancer, and inhibition of this pathway holds the potential to overcome that resistance, according to data presented at the American Association for Cancer Research Molecular Diagnostics in Cancer Therapeutic Development meeting.
